Close Menu

NEW YORK (GenomeWeb) — NanoView Biosciences said today that it has signed an agreement making Quantum Design International the exclusive distributor of its ExoView exosome characterization platform in Japan.

Under the terms of the agreement, Quantum's Tokyo-based subsidiary — called Quantum Design Japan — will distribute the system in Japan, becoming NanoView's first distributor in Asia. Additional terms were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Guardian reports that some UK physicians are calling for increased regulation of direct-to-consumer genetic tests.

US tax agency says 23andMe's genetic health test can be claimed as a medical expense for tax purposes, the Wall Street Journal reports.

Two Democratic lawmakers argue at USA Today that independent science is under attack by the Trump Administration.

In PLOS this week: networks of genes co-expressed in depression, role of minichromosome maintenance genes in lung adenocarcinoma, and more.